Moneycontrol > News > Announcements

Jun 29, 2012, 10.41 AM IST

Alembic and Breckenridge announce paragraph IV ANDA litigation with Pfizer on desvenlafaxine

Alembic and Breckenridge announce paragraph IV ANDA litigation with Pfizer on desvenlafaxine

Source: Moneycontrol.com
Share Share on Tumblr
Share  .  Email  .  Print  .  A+
Breckenridge Pharmaceutical Inc USA and Alembic Pharmaceutical were named codefendants in a paragraph IV lawsuit filed by Pfizer Inc. concerning their ANDA desvenlafaxine succinate extended-release tablets 50mg and 100mg. a generic version of Pristiq by Pfizer Inc. Breckenridge and Alembic filed their paragraph IV ANDA on the first-possible submission date and expects to share 180-day exclusively with other ANDA first filers. Alembic Pharma Ltd. is the sponsor and manufacturer of the ANDA, which will be marketed exclusively by Breckenridge. Source : BSE

Read all announcements in Alembic Pharma


Set email alert for

Action in Alembic Pharmaceuticals
Anti-social Media: Hell is Other People helps you avoid 'friends'
Vajpayee, Advani, Modi: Every leader has given Hindutva a twist "Vajpayee, Advani, Modi: Every leader has given Hindutva a twist"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

Jun 17 2013, 22:16

Subbarao has hit the nail on its head, says Ambit`s Wadhwa

- in MARKET OUTLOOK

Jun 17 2013, 22:17

Pullback on Nifty may continue till 5880: Hemant Thukral

- in MARKET OUTLOOK